97 related articles for article (PubMed ID: 15567318)
1. The interaction between carrier rugosity and carrier payload, and its effect on drug particle redispersion from adhesive mixtures during inhalation.
Dickhoff BH; de Boer AH; Lambregts D; Frijlink HW
Eur J Pharm Biopharm; 2005 Jan; 59(1):197-205. PubMed ID: 15567318
[TBL] [Abstract][Full Text] [Related]
2. A critical evaluation of the relevant parameters for drug redispersion from adhesive mixtures during inhalation.
de Boer AH; Dickhoff BH; Hagedoorn P; Gjaltema D; Goede J; Lambregts D; Frijlink HW
Int J Pharm; 2005 Apr; 294(1-2):173-84. PubMed ID: 15814242
[TBL] [Abstract][Full Text] [Related]
3. The effect of carrier surface treatment on drug particle detachment from crystalline carriers in adhesive mixtures for inhalation.
Dickhoff BH; de Boer AH; Lambregts D; Frijlink HW
Int J Pharm; 2006 Dec; 327(1-2):17-25. PubMed ID: 16920287
[TBL] [Abstract][Full Text] [Related]
4. The mode of drug particle detachment from carrier crystals in an air classifier-based inhaler.
de Boer AH; Hagedoorn P; Gjaltema D; Lambregts D; Irngartinger M; Frijlink HW
Pharm Res; 2004 Dec; 21(12):2167-74. PubMed ID: 15648247
[TBL] [Abstract][Full Text] [Related]
5. The effect of carrier surface and bulk properties on drug particle detachment from crystalline lactose carrier particles during inhalation, as function of carrier payload and mixing time.
Dickhoff BH; de Boer AH; Lambregts D; Frijlink HW
Eur J Pharm Biopharm; 2003 Sep; 56(2):291-302. PubMed ID: 12957644
[TBL] [Abstract][Full Text] [Related]
6. Agglomerate behaviour of fluticasone propionate within dry powder inhaler formulations.
Le VN; Robins E; Flament MP
Eur J Pharm Biopharm; 2012 Apr; 80(3):596-603. PubMed ID: 22198291
[TBL] [Abstract][Full Text] [Related]
7. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
Int J Pharm; 2006 Mar; 310(1-2):81-9. PubMed ID: 16442246
[TBL] [Abstract][Full Text] [Related]
8. Insights into the roles of carrier microstructure in adhesive/carrier-based dry powder inhalation mixtures: Carrier porosity and fine particle content.
Shalash AO; Molokhia AM; Elsayed MM
Eur J Pharm Biopharm; 2015 Oct; 96():291-303. PubMed ID: 26275831
[TBL] [Abstract][Full Text] [Related]
9. Air classifier technology (ACT) in dry powder inhalation. Part 2. The effect of lactose carrier surface properties on the drug-to-carrier interaction in adhesive mixtures for inhalation.
de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Kussendrager KD; Frijlink HW
Int J Pharm; 2003 Jul; 260(2):201-16. PubMed ID: 12842340
[TBL] [Abstract][Full Text] [Related]
10. The rate of drug particle detachment from carrier crystals in an air classifier-based inhaler.
de Boer AH; Hagedoorn P; Gjaltema D; Lambregts D; Irngartinger M; Frijlink HW
Pharm Res; 2004 Dec; 21(12):2158-66. PubMed ID: 15648246
[TBL] [Abstract][Full Text] [Related]
11. The effect of budesonide particle mass on drug particle detachment from carrier crystals in adhesive mixtures during inhalation.
Dickhoff BH; Ellison MJ; de Boer AH; Frijlink HW
Eur J Pharm Biopharm; 2002 Sep; 54(2):245-8. PubMed ID: 12191698
[TBL] [Abstract][Full Text] [Related]
12. Agglomeration tendency in dry pharmaceutical granular systems.
Lachiver ED; Abatzoglou N; Cartilier L; Simard JS
Eur J Pharm Biopharm; 2006 Oct; 64(2):193-9. PubMed ID: 16797949
[TBL] [Abstract][Full Text] [Related]
13. A critical view on lactose-based drug formulation and device studies for dry powder inhalation: which are relevant and what interactions to expect?
de Boer AH; Chan HK; Price R
Adv Drug Deliv Rev; 2012 Mar; 64(3):257-74. PubMed ID: 21565232
[TBL] [Abstract][Full Text] [Related]
14. Development of a Rational Design Space for Optimizing Mixing Conditions for Formation of Adhesive Mixtures for Dry-Powder Inhaler Formulations.
Sarkar S; Minatovicz B; Thalberg K; Chaudhuri B
J Pharm Sci; 2017 Jan; 106(1):129-139. PubMed ID: 27546350
[TBL] [Abstract][Full Text] [Related]
15. Development and characterisation of interactive mixtures with a fine-particulate mucoadhesive carrier for nasal drug delivery.
Fransén N; Björk E; Nyström C
Eur J Pharm Biopharm; 2007 Sep; 67(2):370-6. PubMed ID: 17451925
[TBL] [Abstract][Full Text] [Related]
16. The adhesive strength of non-spherical particles mediated by specific interactions.
Decuzzi P; Ferrari M
Biomaterials; 2006 Oct; 27(30):5307-14. PubMed ID: 16797691
[TBL] [Abstract][Full Text] [Related]
17. Understanding the effect of lactose particle size on the properties of DPI formulations using experimental design.
Guenette E; Barrett A; Kraus D; Brody R; Harding L; Magee G
Int J Pharm; 2009 Oct; 380(1-2):80-8. PubMed ID: 19596428
[TBL] [Abstract][Full Text] [Related]
18. Controlling the performance of adhesive mixtures for inhalation using mixing energy.
Thalberg K; Papathanasiou F; Fransson M; Nicholas M
Int J Pharm; 2021 Jan; 592():120055. PubMed ID: 33176199
[TBL] [Abstract][Full Text] [Related]
19. An investigation into the relationship between carrier-based dry powder inhalation performance and formulation cohesive-adhesive force balances.
Jones MD; Harris H; Hooton JC; Shur J; King GS; Mathoulin CA; Nichol K; Smith TL; Dawson ML; Ferrie AR; Price R
Eur J Pharm Biopharm; 2008 Jun; 69(2):496-507. PubMed ID: 18191553
[TBL] [Abstract][Full Text] [Related]
20. Drug release study of large hollow nanoparticulate aggregates carrier particles for pulmonary delivery.
Hadinoto K; Zhu K; Tan RB
Int J Pharm; 2007 Aug; 341(1-2):195-206. PubMed ID: 17467934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
